CSX vs MPLT · P/E 19, rev $7.42B vs $1.24B cap
CSX Corporation (CSX) versus MapLight Therapeutics, Inc. Common Stock (MPLT) — a side-by-side from cached financials, not a winner call.
CSX Corporation (CSX) is a railroads company listed on US.
MapLight Therapeutics, Inc. Common Stock (MPLT) is a biotechnology company listed on NASDAQ.
Latest reported CSX revenue for 2026-06-30 was $7.42B. Net income was $1.81B. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
MPLT does not have a complete income-statement cache yet.
CSX currently screens at market cap $61.18B and trailing P/E 19.4. MPLT currently screens at market cap $1.24B.
Not investment advice. Open the CSX and MPLT stock pages for the full models.
Not investment advice.